Articles with "enhanced liver" as a keyword



Photo from wikipedia

Can the Enhanced Liver Fibrosis Score Be Used to Diagnose Children With Liver Fibrosis?

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Pediatric Gastroenterology and Nutrition"

DOI: 10.1097/mpg.0000000000003316

Abstract: Supplemental Digital Content is available in the text ABSTRACT Objectives: The noninvasive Enhanced Liver Fibrosis (ELF) score is used in adults with liver fibrosis as a diagnostic aid. The ELF score combines 3 serum markers… read more here.

Keywords: elf score; fibrosis; enhanced liver; elf scores ... See more keywords
Photo from wikipedia

Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of Investigative Medicine"

DOI: 10.1136/jim-2017-000609

Abstract: Data on cytokeratin-18 (K-18) and enhanced liver fibrosis (ELF) score in insulin-treated diabetes patients with non-alcoholic fatty liver disease (NAFLD) are limited. This study analyzed phase III data comparing basal insulin peglispro (BIL) and insulin… read more here.

Keywords: insulin; range; enhanced liver; type ... See more keywords
Photo from wikipedia

Contrast-enhanced US of the Liver and Kidney: A Problem-solving Modality.

Sign Up to like & get
recommendations!
Published in 2022 at "Radiology"

DOI: 10.1148/radiol.211347

Abstract: Contrast-enhanced US (CEUS) has an important role as a supplement to CT or MRI in clinical practice. The main established utilizations are in the liver and the kidney. The primary advantages of CEUS compared with… read more here.

Keywords: kidney problem; contrast; enhanced liver; liver kidney ... See more keywords
Photo from wikipedia

Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Pharmacology"

DOI: 10.3389/fphar.2022.891398

Abstract: Background: In more than 90% of chronic viral hepatitis C (HCV) patients treated with direct-acting antiviral agents (DAAs), a sustained viral response (SVR) was observed. Unfortunately, there are subgroups of subjects who display enduring liver… read more here.

Keywords: liver fibrosis; antiviral agents; enhanced liver; direct acting ... See more keywords